Onkure Therapeutics, Inc. · NASDAQ:OKUR
BVF PARTNERS L P/IL reported a 8.00% stake in Onkure Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
BVF PARTNERS L P/IL reported a 8.00% stake in Onkure Therapeutics, Inc., 3,235,778 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 3,235,778
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 4.10% | 1,671,617 |
| BVF I GP LLC | 4.10% | 1,671,617 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.20% | 1,289,385 |
| BVF II GP LLC | 3.20% | 1,289,385 |
| Biotechnology Value Trading Fund OS LP | 0.60% | 226,497 |
| BVF Partners OS Ltd. | 0.60% | 226,497 |
| BVF GP HOLDINGS LLC | 7.30% | 2,961,002 |
| BVF PARTNERS L P/IL | 8.00% | 3,235,778 |
| BVF INC/IL | 8.00% | 3,235,778 |
| LAMPERT MARK N | 8.00% | 3,235,778 |
Source
Related
- Onkure Therapeutics, Inc.
- Bvf Partners L P
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · Bvf Partners L P · May 27, 2026
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Prosight Management, LP · Aug 10, 2026